Lansoprazole 30mg
Sponsors
AstraZeneca, Inje University, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Onconic Therapeutics Inc., SUK MIN SEO
Conditions
Acute Coronary Syndromes (ACS)Coronary Artery Disease (CAD)Gastric UlcerGastroesophageal Reflux DiseaseGrönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Helicobacter Pylori Infection
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
CompletedNCT05448001
Start: 2022-09-19End: 2024-07-19Updated: 2024-08-26
Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
Not yet recruitingNCT07730138
Start: 2026-10-15End: 2028-10-15Target: 384Updated: 2026-07-28
Phase 4
Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
CompletedNCT00410592
Start: 2006-10-31End: 2007-05-31Target: 90Updated: 2009-03-11
Helicobacter Pylori Eradication Study
CompletedNCT03130452
Start: 2016-12-17End: 2019-05-31Updated: 2025-05-01
Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)
NCT04660461
Start: 2020-02-04End: 2021-06-24Target: 20Updated: 2020-12-09